Table 1 Results for newly identified and previously reported risk variants associated with uterine leiomyoma at P < 6.6 × 10−9 in Japanese populations.

From: Identification of a novel uterine leiomyoma GWAS locus in a Japanese population

SNP

Locus

Nearest Gene

Non Reference Allele

Reference Allele

GWAS Screening Stage 1

Screening Stage 2

Replication stage

Combined

OR

95% CI

P

OR

95% CI

P

OR

95% CI

P

OR

95% CI

P

Heterogeneity

Qa

I2 b

Newly Identified Locus

rs17033114

12q23.2

LINC00485

T

C

1.147

1.084-1.214

2.62E-06

1.185

1.135-1.237

2.25E-14

1.200

1.118-1.288

4.52E-07

1.177

1.141-1.213

6.12E-25

0.556

0.000

Reported Loci

rs3820282

1p36.12

WNT4

C

T

0.854

0.816-0.893

3.19E-12

0.853

0.825-0.882

5.42E-20

0.870

0.817-0.927

1.58E-05

0.856

0.835-0.877

3.49E-35

0.856

0.000

rs12479436

2p25.1

GREB1

G

T

1.094

1.046-1.144

6.45E-05

1.144

1.107-1.183

5.06E-15

1.072

1.006-1.141

3.09E-02

1.118

1.090-1.145

9.50E-19

0.109

54.970

rs2251795

3q26.2

MYNN

A

T

0.882

0.843-0.923

5.89E-08

0.910

0.878-0.943

9.08E-08

0.933

0.874-0.996

3.83E-02

0.904

0.882-0.928

1.24E-14

0.333

8.950

rs2242652

5p15.33

TERT

G

A

0.891

0.847-0.938

1.03E-05

0.900

0.865-0.936

1.70E-07

0.885

0.823-0.952

9.64E-04

0.895

0.870-0.921

2.42E-14

0.905

0.000

rs75228775

10q24.33

SLK

C

T

0.755

0.698-0.817

1.28E-12

0.751

0.708-0.796

2.98E-21

0.813

0.726-0.910

3.22E-04

0.761

0.729-0.795

7.45E-35

0.465

0.000

rs2280543

11p15.5

SIRT3

C

T

1.393

1.296-1.498

3.99E-19

1.337

1.266-1.412

2.15E-25

1.279

1.157-1.414

1.54E-06

1.344

1.296-1.394

2.05E-47

0.384

0.000

rs7989971

13q14.11

FLJ42392

C

G

1.122

1.073-1.174

5.14E-07

1.067

1.030-1.105

2.23E-04

1.071

1.005-1.140

3.39E-02

1.085

1.058-1.113

3.33E-10

0.207

36.590

rs12484776

22q13.1

TNRC6B

A

G

0.837

0.800-0.876

4.16E-15

0.937

0.905-0.971

2.11E-04

0.870

0.816-0.927

2.03E-05

0.893

0.871-0.916

4.63E-18

0.000

87.260

  1. aQ for heterogeneity across all studies was calculated using Cochran’s Q test.
  2. bI2, heterogeneity index.